Overview

Gender

male

Dan Faga joined Mirati in January 2020 as Chief Operating Officer. Dan brings 20 years of biopharma industry experience to his leadership of the company’s corporate strategy, program & alliance management, finance, business development legal & compliance, and investor relations & corporate affairs functions.

Dan joins Mirati from Spark Therapeutics (acquired by Roche), where he served as Chief Business Officer, a position he held since 2016. He was responsible for the Corporate Strategy and Public Affairs organization, including leadership of Spark’s corporate strategy, portfolio and new product planning, patient advocacy, business development, alliance management, asset and program management, and corporate communications functions.

Prior to joining Spark Therapeutics, Dan was a Managing Director at Centerview Partners where he served from 2009 – 2016 as a founding member of the firm’s Healthcare Advisory Practice. Primarily focused on the life sciences sector, he has extensive experience in corporate strategy, mergers and acquisitions, partnerships, investor relations, and has advised on over $50 Billion in biopharma transactions.

Dan’s experience also includes healthcare investment banking with Merrill Lynch and management consulting in the life sciences practice at PRTM.